597 related articles for article (PubMed ID: 11318654)
1. A photolysis-triggered heme ligand switch in H93G myoglobin.
Franzen S; Bailey J; Dyer RB; Woodruff WH; Hu RB; Thomas MR; Boxer SG
Biochemistry; 2001 May; 40(17):5299-305. PubMed ID: 11318654
[TBL] [Abstract][Full Text] [Related]
2. Proximal ligand motions in H93G myoglobin.
Franzen S; Peterson ES; Brown D; Friedman JM; Thomas MR; Boxer SG
Eur J Biochem; 2002 Oct; 269(19):4879-86. PubMed ID: 12354119
[TBL] [Abstract][Full Text] [Related]
3. Trans effects in nitric oxide binding to myoglobin cavity mutant H93G.
Decatur SM; Franzen S; DePillis GD; Dyer RB; Woodruff WH; Boxer SG
Biochemistry; 1996 Apr; 35(15):4939-44. PubMed ID: 8664286
[TBL] [Abstract][Full Text] [Related]
4. 19F NMR of trifluoroacetyl-labeled cysteine mutants of myoglobin: structural probes of nitric oxide bound to the H93G cavity mutant.
Thomas MR; Boxer SG
Biochemistry; 2001 Jul; 40(29):8588-96. PubMed ID: 11456499
[TBL] [Abstract][Full Text] [Related]
5. Investigations of photolysis and rebinding kinetics in myoglobin using proximal ligand replacements.
Cao W; Ye X; Sjodin T; Christian JF; Demidov AA; Berezhna S; Wang W; Barrick D; Sage JT; Champion PM
Biochemistry; 2004 Aug; 43(34):11109-17. PubMed ID: 15323570
[TBL] [Abstract][Full Text] [Related]
6. Proximal ligand control of heme iron coordination structure and reactivity with hydrogen peroxide: investigations of the myoglobin cavity mutant H93G with unnatural oxygen donor proximal ligands.
Roach MP; Puspita WJ; Watanabe Y
J Inorg Biochem; 2000 Aug; 81(3):173-82. PubMed ID: 11051562
[TBL] [Abstract][Full Text] [Related]
7. Investigations of the myoglobin cavity mutant H93G with unnatural imidazole proximal ligands as a modular peroxide O-O bond cleavage model system.
Roach MP; Ozaki S; Watanabe Y
Biochemistry; 2000 Feb; 39(6):1446-54. PubMed ID: 10684626
[TBL] [Abstract][Full Text] [Related]
8. Alkylamine-ligated H93G myoglobin cavity mutant: a model system for endogenous lysine and terminal amine ligation in heme proteins such as nitrite reductase and cytochrome f.
Du J; Perera R; Dawson JH
Inorg Chem; 2011 Feb; 50(4):1242-9. PubMed ID: 21250678
[TBL] [Abstract][Full Text] [Related]
9. Assignment of the heme axial ligand(s) for the ferric myoglobin (H93G) and heme oxygenase (H25A) cavity mutants as oxygen donors using magnetic circular dichroism.
Pond AE; Roach MP; Sono M; Rux AH; Franzen S; Hu R; Thomas MR; Wilks A; Dou Y; Ikeda-Saito M; Ortiz de Montellano PR; Woodruff WH; Boxer SG; Dawson JH
Biochemistry; 1999 Jun; 38(23):7601-8. PubMed ID: 10360958
[TBL] [Abstract][Full Text] [Related]
10. Inversion of axial coordination in myoglobin to create a "proximal" ligand binding pocket.
Uno T; Sakamoto R; Tomisugi Y; Ishikawa Y; Wilkinson AJ
Biochemistry; 2003 Sep; 42(34):10191-9. PubMed ID: 12939147
[TBL] [Abstract][Full Text] [Related]
11. Identification of histidine 77 as the axial heme ligand of carbonmonoxy CooA by picosecond time-resolved resonance Raman spectroscopy.
Uchida T; Ishikawa H; Ishimori K; Morishima I; Nakajima H; Aono S; Mizutani Y; Kitagawa T
Biochemistry; 2000 Oct; 39(42):12747-52. PubMed ID: 11041838
[TBL] [Abstract][Full Text] [Related]
12. 1H NMR characterization of myoglobins where exogenous ligands replace the proximal histidine.
Decatur SM; Boxer SG
Biochemistry; 1995 Feb; 34(7):2122-9. PubMed ID: 7857922
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen bonding modulates binding of exogenous ligands in a myoglobin proximal cavity mutant.
Decatur SM; Belcher KL; Rickert PK; Franzen S; Boxer SG
Biochemistry; 1999 Aug; 38(34):11086-92. PubMed ID: 10460164
[TBL] [Abstract][Full Text] [Related]
14. Role of heme iron coordination and protein structure in the dynamics and geminate rebinding of nitric oxide to the H93G myoglobin mutant: implications for nitric oxide sensors.
Negrerie M; Kruglik SG; Lambry JC; Vos MH; Martin JL; Franzen S
J Biol Chem; 2006 Apr; 281(15):10389-98. PubMed ID: 16476730
[TBL] [Abstract][Full Text] [Related]
15. The H93G myoglobin cavity mutant as a versatile template for modeling heme proteins: ferrous, ferric, and ferryl mixed-ligand complexes with imidazole in the cavity.
Pond AE; Roach MP; Thomas MR; Boxer SG; Dawson JH
Inorg Chem; 2000 Dec; 39(26):6061-6. PubMed ID: 11151505
[TBL] [Abstract][Full Text] [Related]
16. Modulation of protein function by exogenous ligands in protein cavities: CO binding to a myoglobin cavity mutant containing unnatural proximal ligands.
Decatur SM; DePillis GD; Boxer SG
Biochemistry; 1996 Apr; 35(13):3925-32. PubMed ID: 8672423
[TBL] [Abstract][Full Text] [Related]
17. A resonance Raman enhancement mechanism for axial vibrational modes in the pyridine adduct of myoglobin proximal cavity mutant (H93G).
Franzen S; Brown D; Gaff J; Delley B
J Phys Chem B; 2012 Sep; 116(35):10514-21. PubMed ID: 22632602
[TBL] [Abstract][Full Text] [Related]
18. Investigations of heme ligation and ligand switching in cytochromes p450 and p420.
Sun Y; Zeng W; Benabbas A; Ye X; Denisov I; Sligar SG; Du J; Dawson JH; Champion PM
Biochemistry; 2013 Aug; 52(34):5941-51. PubMed ID: 23905516
[TBL] [Abstract][Full Text] [Related]
19. Identification of conformational substates involved in nitric oxide binding to ferric and ferrous myoglobin through difference Fourier transform infrared spectroscopy (FTIR).
Miller LM; Pedraza AJ; Chance MR
Biochemistry; 1997 Oct; 36(40):12199-207. PubMed ID: 9315857
[TBL] [Abstract][Full Text] [Related]
20. FTIR and resonance Raman studies of nitric oxide binding to H93G cavity mutants of myoglobin.
Thomas MR; Brown D; Franzen S; Boxer SG
Biochemistry; 2001 Dec; 40(49):15047-56. PubMed ID: 11732927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
